Citation: J. Frantsve et al., Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation, MOL CELL B, 21(10), 2001, pp. 3547-3557
Authors:
Tomasson, MH
Williams, IR
Li, SG
Kutok, J
Cain, D
Gillessen, S
Dranoff, G
Van Etten, RA
Gilliland, DG
Citation: Mh. Tomasson et al., Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factoror interleukin-3, BLOOD, 97(5), 2001, pp. 1435-1441
Authors:
Schwaller, J
Anastasiadou, E
Cain, D
Kutok, J
Wojiski, S
Williams, IR
LaStarza, R
Crescenzi, B
Sternberg, DW
Andreasson, P
Schiavo, R
Siena, S
Mecucci, C
Gilliland, DG
Citation: J. Schwaller et al., H4(D10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived growth factor receptor beta gene in atypical chronic myeloid leukemia with t(5;10)(q33;q22), BLOOD, 97(12), 2001, pp. 3910-3918
Authors:
Liu, Q
Schwaller, J
Kutok, J
Cain, D
Aster, JC
Williams, IR
Gilliland, DG
Citation: Q. Liu et al., Signal transduction and transforming properties of the TEL-TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia, EMBO J, 19(8), 2000, pp. 1827-1838